THE SYNTHESIS OF AN INTERNAL STANDARD FOR BICALUTAMIDE
(R,S)-Bicalutamide [N-(4-cyano-3-trifluoromethylphenyl)-α-methyl-α-hydroxy-β-(4- fluorophenylsulfonyl)propanamide], sold as Casodex®, is the leading antiandrogen currently used to treat prostate cancer. It binds to androgen receptors and blocks cancer growth. This work aims to develop internal s...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en-uk |
| Published: |
University of the Free State
2009
|
| Subjects: | |
| Online Access: | http://etd.uovs.ac.za//theses/available/etd-04082009-151002/restricted/ |